Third Year Resident
Start Year
2019
What are your career interests?
Skin of color, procedural dermatology, increasing access of dermatologic care to underserved populations
Why did you choose Duke for residency training?
I chose Duke because there are few institutions that aim for excellence with a humble, collaborative approach. I know that Duke is a place where I will not only see diverse pathology, but also be surrounded by a supportive health system that is focused on increasing the quality of care delivered to patients, and expanding the reach of this care to the underserved.
Education & Training
Undergraduate: Duke University, BA, Chemistry, 2012
Medical School: University of Tennessee Health Science Center, MD, 2018
Internship: Internal Medicine, University of Tennessee Health Science Center, 2018-2019
Residency: Dermatology, Duke University, 2019-2022
Awards & Honors
- BioLegend Outstanding Abstract Award, Graduate Student Category, UTHSC Pediatric Research Day
- NYU Ronald O. Perelman Department of Dermatology Diversity Clerkship Award
- American Academy of Dermatology Diversity Mentorship Award
- Mid-South Scholarship, UTHSC College of Medicine, 2014-2018
Publications & Presentations
- Brown Lobbins ML, Scott IS, Slominski AT, Hasty KA, Zhang S, Miller DD, Li W, Kim T-K, Janjetovic Z, Patel TS, Myers LK, Postlethwaite AE. 17,20S(OH)2pD Can Prevent the Development of Skin Fibrosis in the Bleomycin-Induced Scleroderma Mouse Model. International Journal of Molecular Sciences. August 2021; 22(16):8926.
- Scott, IS., Atwater, A., Reader M. “Update on Contact Dermatitis and Patch Testing in Patients with Skin of Color.” Cutis. 2021 Jul;108(1):10-12.
- Scott, IS., Lobbins, M., Slominski, A., Hasty, K., Miller, D., Li, W., Kim, TK., Tuckey, R., Postlethwaite, A. “17,20S(OH)2pD Suppresses Total Collagen Synthesis in the Bleomycin Model of Fibrosis.” Journal of Investigative Medicine 2018;66:562.
- Scott, IS., Lobbins, M., Slominski, A., Hasty, K., Miller, D., Li, W., Kim, TK., Tuckey, R., Postlethwaite, A. “17,20S(OH)2pD Suppresses Total Collagen Synthesis in the Bleomycin Model of Fibrosis.” Southern Society for Clinical Investigation, Southern Regional Meeting. New Orleans, LA. February 23, 2018.
- Scott, IS., Lobbins, M., Slominski, A., Hasty, K., Miller, D., Li, W., Kim, TK., Tuckey, R., Postlethwaite, A. “17,20S(OH)2pD Suppresses Total Collagen Synthesis in the Bleomycin Model of Fibrosis.” Pediatric Research Day, LeBonheur Children’s Hospital. Memphis, TN. March 28, 2018.